ClinicalTrials.gg
Sign In

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative clinical trials

The registry lists 209 studies for Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative across more than 10 countries. 9 are recruiting or about to start. 16 of them are mainly about Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
140
Terminated
35
Withdrawn
10
Status unknown
9
Recruiting
8
Active, not recruiting
6

Phase

Phase 2
91
Phase 1
58
Phase 3
18
Early Phase 1
2

Where

United States
179
Canada
9
Germany
7
Switzerland
6
France
5
Italy
5

Who runs them

Fred Hutchinson Cancer Center (22) · National Cancer Institute (NCI) (18) · Case Comprehensive Cancer Center (15) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (11) · Memorial Sloan Kettering Cancer Center (10) · City of Hope Medical Center (9) · Roswell Park Cancer Institute (8) · OHSU Knight Cancer Institute (8)

What is being tested here

Drugs under test in Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ruxolitinib103
Ropeginterferon alfa-2b101
Axatilimab101
Onvansertib101
Hyperbaric Oxygen101
Abatacept101
Fludarabine phosphate0124
Fludarabine0124
Cyclophosphamide0122
Busulfan0117

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open · Antimetabolites 39 · Alkylating agents 33 · Calcineurin inhibitors 14

Coming up

0phase 3 studies under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 8 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative studies recruiting now, 5 (63%) set no upper age limit and 2 (25%) stop at 75 or younger. 1 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
101 (13%)1 (13%)
187 (88%)7 (88%)
307 (88%)7 (88%)
407 (88%)7 (88%)
507 (88%)7 (88%)
658 (100%)8 (100%)
757 (88%)7 (88%)
856 (75%)6 (75%)

Across all 209 studies, recruiting or not: 36% stop at 75 or younger and 25% at 65; 41% take children; 0% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 209. Browse all 209 → or search them.